Latest database descriptions

The primary objective is to establish the incidence of orthopaedic complications (scoliosis and hip joint) depending on patients' age.
Secondary objectives are to describe the sequences over time of these complications and the related pain, to explore the impact of nutrition, surgery, asymmetric postures and environmental factors, and to describe the medical and rehabilitative follow-up of these patients.

Evaluate on a prospective basis the predictive value of ANS activity, and its decline during the follow-up, on the occurrence of serious cerebral events, and on mortality all cause considered, in a general population of homogeneous age, 65 at inclusion.

Secondary objectives have been defined, analyzing the association between ANS and:
1) The presence and severity of cerebrovascular accidents at NRM imaging;
2) Neuropsychological performances;
3) Classic cardiovascular risk factors;
4) Genetic of the specific receptors of the neurotransmitters directly implied;
5) Sleep respiratory pathologies;
6) Realization of temporal analysis to determine chronological sequences of the decline of ANS activity and pathological conditions occurrence, including emerging conditions, such as sleep respiratory pathologies.

In this study we will examine patients who have undergone anterior cruciate and/or posterior cruciate ligament and/or multi ligaments reconstruction to determine the rate of re-injury, contralateral tear and functional outcomes at least two years after surgery.

To describe the treatment patterns of advanced (unresectable locally advanced or metastatic) STS (including viscus sarcoma) patients in France.

Secondary objectives:
- To describe STS (including viscus sarcoma) patients characteristics (sociodemographic data, type of sarcoma, histological subtype, tumor location, stage of the disease etc).
- To assess the STS (including viscus sarcoma) incidence in France
- To describe STS diagnosis (anatomopathology double review) and treatment history
- To describe the duration of the different treatments of STS disease